SHH Equity Snapshot
688520 Weekly Equity Report
Sinocelltech Group Limited
What the company does
Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma; Anjiarun, an adalimumab biosimilar for the treatment of various autoimmune diseases; Anbezu, a bevacizumab biosimilar for the treatment of various solid tumors; SCTV01, a series of recombinant protein vaccines for multiple variants of the new coronavirus; Fenolimab, a recombinant humanized anti-PD-1 …
What the weekly tape is saying
688520 closed the latest completed week at 34.55 CNY. The 4-week return is -17.9% and the 12-week return is -9.1%. Trend Signal is inactive, Market Dynamics is -0.18. Setup signature: Risk-first tape with a 13/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 42.53 CNY
- Vs Trend Line
- -18.8%
- Fair Value
- 46.40 CNY
- Vs Fair Value
- -25.5%
- 52W High
- 89.04 CNY
- 52W Low
- 32.69 CNY
- Drawdown
- -61.2%
- Range Position
- 3.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 18
- 52W Active Breadth
- 34.6%
- Sector Scope
- CN Healthcare
- Sector Rank
- 260 of 486
- Sector Percentile
- 46.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
CN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 88 of 100
- Avg 1W
- -0.2%
- Avg 4W
- -7.7%
- Trend Breadth
- 15.0%
- Positive MD
- 24.0%
CN Biotechnology
- Tracked Peers
- 100
- 4W Rank
- 75 of 100
- Avg 1W
- -1.1%
- Avg 4W
- -13.2%
- Trend Breadth
- 13.0%
- Positive RS
- 10.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.18
- 4W MD Change
- -151.4%
- Relative Strength
- -35.20
- 4W RS Change
- -44.9%
- Expectation
- Negative
- Probability
- 42.73%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 9.3M
- 13W Average
- 14.7M
- 52W Average
- 20.6M
- Vs 13W
- 0.6x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.7%
- 52W Volatility
- 9.6%
- Upside Weeks
- 19
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 8.1% / -4.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- SHH
- Country
- CN
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- CNY
- Market Cap
- 17.4B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 34.55 CNY | -2.4% | 42.53 CNY | 46.40 CNY | -0.18 | -35.20 | 9.3M | Off |
| 5 Jun 2026 | 35.40 CNY | -7.5% | 43.04 CNY | 46.59 CNY | 0.31 | -34.04 | 13.3M | Off |
| 29 May 2026 | 38.25 CNY | -5.9% | 43.65 CNY | 46.76 CNY | 0.54 | -29.75 | 10.7M | Off |
| 22 May 2026 | 40.65 CNY | -3.4% | 44.11 CNY | 46.91 CNY | 0.51 | -26.40 | 13.2M | Off |
| 15 May 2026 | 42.10 CNY | -0.4% | 44.51 CNY | 47.07 CNY | 0.35 | -24.30 | 17.6M | Off |
| 8 May 2026 | 42.29 CNY | 2.7% | 44.93 CNY | 47.24 CNY | 0.37 | -24.84 | 10.5M | Off |
| 1 May 2026 | 41.18 CNY | 0.8% | 45.38 CNY | 47.47 CNY | 0.40 | -25.72 | 9.2M | Off |
| 24 Apr 2026 | 40.85 CNY | -7.7% | 45.83 CNY | 47.67 CNY | 0.60 | -25.90 | 17.2M | Off |
| 17 Apr 2026 | 44.25 CNY | 5.6% | 46.40 CNY | 47.82 CNY | 0.66 | -19.34 | 20.7M | Off |
| 10 Apr 2026 | 41.90 CNY | 0.6% | 46.92 CNY | 47.93 CNY | 0.19 | -22.51 | 15.1M | Off |
| 3 Apr 2026 | 41.67 CNY | 0.5% | 47.62 CNY | 48.07 CNY | -0.12 | -21.05 | 24.0M | Off |
| 27 Mar 2026 | 41.46 CNY | 9.1% | 48.35 CNY | 48.22 CNY | -0.42 | -22.29 | 16.9M | Off |
| 20 Mar 2026 | 38.00 CNY | -3.6% | 49.24 CNY | 48.39 CNY | -0.73 | -29.65 | 13.1M | Off |
| 13 Mar 2026 | 39.40 CNY | -1.2% | 50.41 CNY | 48.57 CNY | -0.77 | -29.71 | 10.8M | Off |